台股 » 個股 » 智基 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

智基

(6294)
可現股當沖
  • 股價
    117.5
  • 漲跌
    ▼0.5
  • 漲幅
    -0.42%
  • 成交量
    42
  • 產業
    上櫃 文化創意指數
  • 106人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
智基 (6294)籌碼相關-台灣企銀-豐原 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

台灣企銀-豐原 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/01/0300.0010114.40114.00-1025-38.89%
2023/12/202114.0000.00114.502238.49%
2023/12/188114.0000.00114.0082334.76%
2020/06/3000.000.2107.50107.50-0.262-0.36%
2020/05/2100.006109.17110.00-652-11.36%
2020/05/2000.002108.75109.00-252-3.84%
2020/05/1800.003107.67108.00-351-5.88%
2020/05/1400.003109.00108.50-349-6.01%
2020/04/22198.9000.0099.601442.25%
2020/04/161100.5000.00100.001432.33%
2020/04/0100.00196.6096.60-142-2.35%
2020/03/2400.00195.0094.00-139-2.56%
2020/03/20184.5000.0084.501382.58%
2020/03/1700.00391.1790.90-335-8.53%
2020/03/1600.00193.2093.00-134-2.92%
2020/03/1300.00294.0095.10-233-6.03%
2020/03/1200.00298.2598.10-230-6.66%
2020/02/2500.001101.00101.00-125-3.85%
2020/02/1800.001101.00101.00-125-3.86%
2020/02/0600.001102.00101.50-127-3.64%
2019/12/1800.002102.75102.50-220-9.98%
2019/07/011110.5000.00111.001412.40%
2019/06/202110.5000.00110.502385.16%
2019/05/2400.001110.50109.00-142-2.37%
2019/05/2300.002108.75108.50-242-4.75%
2019/05/131105.0000.00106.501422.35%
2019/04/191107.5000.00107.501382.57%
2019/03/291108.5000.00108.501323.11%
2019/03/191111.0000.00111.501283.45%
2019/03/072109.5000.00109.002257.82%
2019/02/251109.0000.00110.001234.17%
2019/02/201108.5000.00108.501234.32%
2018/11/2100.001103.50104.00-129-3.42%
2018/11/2000.001103.00103.00-129-3.41%
2018/11/1600.002103.50103.50-229-6.85%
2018/10/1800.001101.00100.50-139-2.51%
2018/10/1500.00299.8099.60-243-4.55%
2018/10/1100.001100.5098.80-144-2.25%
2018/10/0800.002103.00102.00-245-4.44%
2018/09/101104.5000.00104.501531.88%
2018/07/2300.001126.50126.50-185-1.17%
2018/07/2000.001127.00126.50-184-1.19%
2018/07/031120.5000.00121.001881.13%
2018/07/021122.5000.00122.001891.12%
2018/06/2100.002126.00125.50-298-2.03%
2018/06/2000.001124.00124.00-199-1.00%
2018/06/1900.002123.00124.00-2102-1.94%
2018/05/161124.5000.00125.0011280.78%
2018/05/112126.0000.00124.5021301.53%
2018/05/091128.0000.00129.0011270.79%
2018/05/0700.003131.83131.50-3124-2.41%
2018/04/2700.001124.00124.00-1117-0.85%
2018/04/2600.004121.25121.00-4120-3.31%
2018/04/241122.5000.00122.0011390.72%
2018/04/202123.5000.00124.0021521.31%
2018/04/091126.0000.00127.0011640.61%
2018/03/2300.001124.00124.00-1166-0.60%
2018/03/221125.0000.00125.5011700.59%
2018/03/2100.001131.00128.50-1183-0.54%
2018/03/192127.5000.00127.5021761.13%
2018/03/062118.0000.00119.5021761.13%
2018/03/0200.002121.00120.00-2175-1.14%
2018/02/262117.752121.00116.5001720.00%
2018/02/2300.003118.33117.00-3169-1.77%
2018/02/2100.001116.00116.50-1168-0.59%
2018/02/0900.003114.00116.00-3166-1.80%
2018/01/302121.0000.00120.0021621.23%
2018/01/297121.2100.00123.0071624.32%
2018/01/1900.003125.67124.00-3148-2.02%
2018/01/171121.005120.30121.50-4129-3.09%
2018/01/1500.002117.00118.00-2114-1.74%
2018/01/0400.001112.50112.00-198-1.02%
2018/01/021107.0000.00107.501951.04%
慧智基因前列腺癌基因檢測套組 推行至國內千名患者Anue鉅亨-2021/09/14
疫情推升醫材需求強 雃博5月營收創同期高 慧智基因寫新猷Anue鉅亨-2021/06/10
智基 相關文章
智基 相關影音